Pharmaceuticals Content

Receptor Location Matters for Psychedelic Drug Effects

Andy Fell — February 16, 2023 - 11:00am

A new study reveals receptor location impacts psychedelic drug effects. Learn how �°��ϲ��Ļ��Ϣ Davis researchers are exploring implications for mental health treatment.

Plant Product Shows Promise in Mouse Model of Parkinson’s Disease

Andy Fell — February 18, 2022 - 3:40pm

A natural product from the dried root of a pea-family plant, potentially combined with an enzyme inhibitor discovered in the laboratory of Professor Bruce Hammock at the University of California, Davis, may provide hope in alleviating neuroinflammation in Parkinson’s disease, a team of researchers from Dalian Medical University, China, and �°��ϲ��Ļ��Ϣ Davis announced Feb 21 in Proceedings of the National of Academy of Scien

Synthetic Version of CBD Treats Seizures in Rats

Andy Fell — May 28, 2019 - 8:52am

A synthetic, non-intoxicating analogue of cannabidiol (CBD) is effective in treating seizures in rats, according to research by chemists at the University of California, Davis. The synthetic CBD alternative is easier to purify than a plant extract, eliminates the need to use agricultural land for hemp cultivation, and could avoid legal complications with cannabis-related products. The work was recently published in the journal Scientific Reports.